Customied Enzyme Modification Solutions

Molefuture Biotech currently has six major technological platforms: ZymeEditor innovative enzyme evolution platform, multi-host high-efficiency expression platform, fermentation process development platform, purification process development platform, UCF·ME® ultra-clean enzyme production platform, and enzyme analysis and quality control platform. Among them, the ZymeEditor™ platform seamlessly integrates directed evolution and rational design techniques. It autonomously incorporates cutting-edge enzyme evolution technologies, including Fluorescence-Activated Droplet Sorting(FADS), alongside traditional methods like Microtiter Plate Screening(MTPS) and forfront Computer-Aided Rational Design(CARD). Through cross-screening utilizing these technologies, ZymeEditor significantly enhances the efficacy of enzyme evolution, leading to the optimization of various enzyme properties such as activity, stability, selectivity, and more. Currently, Molefuture can provide end to end customized solutions including enzyme-directed evolution, novel enzyme development, enzyme production process development, and GMP-level scale production to meet the application needs of enzymes in the fields of in vitro diagnostics, biopharmaceuticals, synthetic biology, medical aesthetics, pharmaceutical intermediates, and beyond.